SCARA5 activators belong to a specialized class of chemical compounds known for their ability to modulate the activity of Scavenger Receptor Class A Member 5 (SCARA5), a transmembrane protein belonging to the scavenger receptor family. SCARA5 is involved in cellular processes related to the recognition and clearance of various ligands, particularly modified low-density lipoproteins (LDLs) and apoptotic cells. These activators are designed to interact with SCARA5, potentially influencing its functions and affecting ligand uptake and cellular responses. At the molecular level, the mechanisms through which SCARA5 activators exert their effects can involve binding to specific regions of the protein, modulating its conformation, or influencing downstream signaling pathways.
Research on SCARA5 activators is fundamental for advancing our understanding of cellular processes related to lipid metabolism, homeostasis, and immune responses. Scientists in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact SCARA5's function and their downstream effects on cellular lipid uptake and recognition of apoptotic cells. SCARA5 is expressed in various tissues, including the liver, kidney, and immune cells, where it plays a role in maintaining lipid homeostasis and facilitating immune responses. Moreover, these activators serve as valuable tools for researchers seeking to investigate the molecular basis of scavenger receptor function and its implications in various physiological contexts, ultimately deepening our understanding of cellular biology and host defense mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPARγ agonist, it might influence SCARA5 expression through PPARγ-mediated pathways, given the receptor's role in lipid metabolism and homeostasis. | ||||||
15-Deoxy-δ12,14-Prostaglandin J2 | 87893-55-8 | sc-201262 sc-201262A | 1 mg 5 mg | $141.00 $551.00 | 5 | |
A natural ligand for PPARγ; could potentially influence SCARA5 expression through PPARγ. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Another PPARγ agonist; may influence SCARA5 expression through PPAR signaling. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
May affect SCARA5 expression through PPARγ-mediated regulation of lipid metabolism and insulin sensitization. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
As a PPARα agonist, it could potentially influence lipid-related receptors like SCARA5. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Given its role in lipid lowering, it may have an indirect effect on SCARA5 expression through alterations in lipid metabolism. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
May influence SCARA5 indirectly due to its role in cholesterol reduction. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Its effects on cholesterol synthesis might influence SCARA5 expression indirectly. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Could potentially influence SCARA5 due to its role in lipid metabolism. | ||||||
Pravastatin, Sodium Salt | 81131-70-6 | sc-203218 sc-203218A sc-203218B | 25 mg 100 mg 1 g | $69.00 $162.00 $787.00 | 2 | |
May have an indirect effect on SCARA5 expression through its lipid-lowering capacity. | ||||||